Treatment-related leukoencephalopathy in adults with central nervous system lymphoma: a retrospective analysis of 126 patients
Annals of Hematology · 2025
DOI: 10.1007/s00277-024-05989-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Yasutaka Masuda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Methotrexate, Leukoencephalopathies, Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Tokyo.
Abstract (Originalsprache)
Neurotoxicity associated with high-dose chemotherapy and whole brain radiotherapy (WBRT) is one of major complications for patients with central nervous system lymphoma (CNSL). Here we determined the incidence and risk factors of treatment-related leukoencephalopathy (tLE) in a clinical setting. We retrospectively reviewed clinical and radiological findings of 126 patients with (CNSL) treated with high-dose methotrexate with or without intrathecal methotrexate administration (IT MTX) and response-adapted WBRT. During the whole observation period with a median of 38.7 months, tLE was found in 33 patients, most of them asymptomatic, with the median time to development 3.0 months, and the cumulative incidence reaching 29.2% (95% confidence interval, 20.6–38.2%) two years post chemotherapy. By multivariable analysis, IT MTX was identified as the only one significant risk factor (hazard ratio, 4.50; P < 0.001), and the number of IT MTX was associated with the increased incidence and severity of tLE. These findings highlight the frequent neurological complications associated with CNS-directed therapy and confirm the neurotoxicity of IT MTX.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan.
- Clinical Application for Development of Therapy for Rare Disease, The University of Tokyo Hospital, Tokyo, Japan.
- Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan.
- Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan. takehitoyamamoto@g.ecc.u-tokyo.ac.jp.
- Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Förderung
- The University of Tokyo
Zitieren
APA
Masuda, Y., Nara, K., Fujii-Mori, A., Shimura, A., Taoka, K., Watadani, T., Morita, K., Yamamoto, T., Kurokawa, M., & Takada, T. (2025). Treatment-related leukoencephalopathy in adults with central nervous system lymphoma: a retrospective analysis of 126 patients. Annals of Hematology. https://doi.org/10.1007/s00277-024-05989-1
Vancouver
Masuda Y, Nara K, Fujii-Mori A, Shimura A, Taoka K, Watadani T, et al. Treatment-related leukoencephalopathy in adults with central nervous system lymphoma: a retrospective analysis of 126 patients. Annals of Hematology. 2025. doi:10.1007/s00277-024-05989-1
BibTeX
@article{Masuda2025,
author = {Masuda, Yasutaka and Nara, Katsuhiko and Fujii-Mori, Alice and Shimura, Arika and Taoka, Kazuki and Watadani, Takeyuki and Morita, Ken and Yamamoto, Takehito and Kurokawa, Mineo and Takada, Tappei},
title = {Treatment-related leukoencephalopathy in adults with central nervous system lymphoma: a retrospective analysis of 126 patients},
journal = {Annals of Hematology},
year = {2025},
doi = {10.1007/s00277-024-05989-1}
}
EUVIMED